At the three-month mark, participants reported more behaviors associated with restrained eating, and fewer behaviors associated with external or emotional eating
Current GLP-1 medications include: Wegovy (semaglutide) licensed for weight loss Ozempic and Rybelsus (semaglutide) licensed for type 2 diabetes Mounjaro (tirzepatide) licensed for both diabetes and weight loss Liraglutide varies by brand
The Future of Ipamorelin and GHRP-6 Research in Muscle Recovery As research on muscle recovery grows, Ipamorelin and GHRP-6 are likely to remain important
CandelariaP V., Leoh LS, Penichet ML, Daniels-Wells TR
Avoid combining it with medications without checking with your doctor first, as interactions are possible
Both syndromes cause a loss of receptor function